Table 1 Baseline characteristics in patients and healthy controls (n = 295) enrolled in a prospective observational study on amino acid derangements in severe falciparum malaria in Bangladesh.

From: Amino acid derangements in adults with severe falciparum malaria

 

Severe Malaria (n = 88)

Uncomplicated Malaria (n = 71)

SIRS/Sepsis (n = 88)

Healthy Controls (n = 48)

p value

Age (years)

28

(19 to 40)

29

(22 to 45)

35

(23 to 54)

29

(23.5 to 35)

0.016

Female sex

32

36

19

27

37

42

19

40

0.172

BMI

21

(19 to 24)

21

(19 to 24)

22

(20 to 25)

24

(21 to 26)

0.004

Duration of illness (days)

8

(7 to 10)

8

(6 to 11)

9

(5 to 14)

0.01

Anorexia before enrolment (days)

8

(6 to 10)

7

(5 to 11)

7

(4 to 14)

0.025

Mortality

26

(30%)

0

20

(23%)

0

<0.001

Clinical examination

Temperature (°C)

38.3

(37.3 to 39.1)

37.4

(37 to 38.4)

38.4

(38 to 38.9)

36.6

(36.3 to 36.8)

<0.001

Coma depth*

9

(7 to 14)

15

(15 to 15)

15

(11 to 15)

15

(15 to 15)

<0.001

Pulse rate (per minute)

110

(96 to 130)

98

(89 to 109)

107

(92 to 120)

82

(73 to 88)

<0.001

Respiratory rate (per minute)

34

(28 to 42)

24

(24 to 28)

32

(26 to 39)

18

(16 to 20)

<0.001

Oxygen saturation (%)

96

(95 to 97)

97

(96 to 98)

96

(94 to 98)

98

(97 to 98)

<0.001

Mean arterial blood pressure (mm Hg)

81

(72 to 88)

78

(71 to 84)

85

(77 to 98)

93

(89 to 97)

<0.001

Laboratory assessments

Parasitaemia (parasites per µL)

46705

(25541 to 85406)

4321

(1901 to 9819)

0

0

<0.001

PfHPR2 (ng/dL)

4165

(3101 to 5594)

640

(426 to 962)

0

0

<0.001

Glucose (mmol/L)

6.6

(5.2 to 8.3)

6.6

(5.6 to 7.9)

7

(6.1 to 9.4)

5.8

(5.2 to 6.3)

<0.001

Sodium (mmol/L

135

(131 to 139)

135

(132 to 138)

134

(130 to 138)

140

(139 to 141)

<0.001

Potassium (mmol/L)

3.9

(3.5 to 4.3)

3.4

(3.3 to 3.6)

3.5

(3.2 to 3.9)

3.7

(3.5 to 3.9)

<0.001

Chloride (mmol/L)

105

(100 to 110)

103

(98.5 to 106)

98.5

(94.8 to 103)

103

(102 to 105)

<0.001

Creatinine (µmol/L)

122

(82 to 317)

82

(65 to 103)

75.5

(57.5 to 113.3)

72.5

(57.8 to 81.3)

<0.001

Blood urea nitrogen (mmol/L)

40

(25 to 78)

16

(11 to 25)

11.5

(7 to 21.3)

8

(5.8 to 10)

<0.001

Haemoglobin (g/L)

83

(64 to 108)

97

(78 to 115.8)

118

(104 to 133)

134

(120 to 148)

<0.001

White blood cells (x 103/µL)

9.1

(6.6 to 12.8)

6

(4.6 to 7.9)

11.1

(7 to 15)

7.7

(6.3 to 8.8)

<0.001

Platelets (x 103/µL)

32

(19 to 47)

47

(35 to 96)

200

(121 to 277)

228

(191 to 289)

<0.001

pH

7.39

(7.35 to 7.44)

7.43

(7.39 to 7.46)

7.42

(7.38 to 7.45)

7.37

(7.35 to 7.39)

<0.001

pCO2 (mm Hg)

31

(27 to 34)

35

(31 to 36)

34

(31 to 39)

47

(42 to 52)

<0.001

HCO3- (mmol/L)

18.8

(16.3 to 21.1)

22.5

(20.7 to 25)

22.9

(20.1 to 25.1)

26.7

(24.9 to 28.6)

<0.001

Plasma SBD (mmol/L)

6

(3 to 10)

1.5

(−1 to 4)

1

(−0.3 to 5)

−1

(−3 to 0)

<0.001

Anion gap (mmol/L)

16

(14 to 18.8)

15

(13 to 16)

17

(15 to 19)

16

(14 to 17)

<0.001

L-lactate (mmol/L)

3.1

(2 to 4.8)

1.5

(1.1 to 1.8)

1.5

(1.1 to 2)

1.3

(1.1 to 1.6)

<0.001

  1. Data are number (%) or median (IQR) unless otherwise indicated. BMI = body mass index. PfHRP2 = Plasma P. falciparum Histidine Rich Protein 2. pCO2 = partial pressure of carbon dioxide. HCO3- = bicarbonate. SBD = standard base deficit. *Depth of coma was assessed by Glasgow coma scale (3–15). Geometric mean, 95% geometric confidence interval.